Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: final overall survival results from SOLAR-1

03 Mar 2021

F André, E M Ciruelos, D Juric, S Loibl, M Campone, I A Mayer, G Rubovszky, T Yamashita, B Kaufman, Y-S Lu, K Inoue, Z Pápai, M Takahashi, F Ghaznawi, D Mills, M Kaper, M Miller, P F Conte, H Iwata, H S Rugo

Annals of Oncology, 2021 Feb.

Abstract Link

Forse può anche interessarti